Cargando…
SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204754/ https://www.ncbi.nlm.nih.gov/pubmed/32387541 http://dx.doi.org/10.1053/j.gastro.2020.05.009 |
_version_ | 1783530113054277632 |
---|---|
author | Gubatan, John Levitte, Steven Balabanis, Tatiana Patel, Akshar Sharma, Arpita Habtezion, Aida |
author_facet | Gubatan, John Levitte, Steven Balabanis, Tatiana Patel, Akshar Sharma, Arpita Habtezion, Aida |
author_sort | Gubatan, John |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7204754 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | by the AGA Institute |
record_format | MEDLINE/PubMed |
spelling | pubmed-72047542020-05-07 SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California Gubatan, John Levitte, Steven Balabanis, Tatiana Patel, Akshar Sharma, Arpita Habtezion, Aida Gastroenterology Brief Communication by the AGA Institute 2020-09 2020-05-07 /pmc/articles/PMC7204754/ /pubmed/32387541 http://dx.doi.org/10.1053/j.gastro.2020.05.009 Text en © 2020 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Brief Communication Gubatan, John Levitte, Steven Balabanis, Tatiana Patel, Akshar Sharma, Arpita Habtezion, Aida SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California |
title | SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California |
title_full | SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California |
title_fullStr | SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California |
title_full_unstemmed | SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California |
title_short | SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California |
title_sort | sars-cov-2 testing, prevalence, and predictors of covid-19 in patients with inflammatory bowel disease in northern california |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204754/ https://www.ncbi.nlm.nih.gov/pubmed/32387541 http://dx.doi.org/10.1053/j.gastro.2020.05.009 |
work_keys_str_mv | AT gubatanjohn sarscov2testingprevalenceandpredictorsofcovid19inpatientswithinflammatoryboweldiseaseinnortherncalifornia AT levittesteven sarscov2testingprevalenceandpredictorsofcovid19inpatientswithinflammatoryboweldiseaseinnortherncalifornia AT balabanistatiana sarscov2testingprevalenceandpredictorsofcovid19inpatientswithinflammatoryboweldiseaseinnortherncalifornia AT patelakshar sarscov2testingprevalenceandpredictorsofcovid19inpatientswithinflammatoryboweldiseaseinnortherncalifornia AT sharmaarpita sarscov2testingprevalenceandpredictorsofcovid19inpatientswithinflammatoryboweldiseaseinnortherncalifornia AT habtezionaida sarscov2testingprevalenceandpredictorsofcovid19inpatientswithinflammatoryboweldiseaseinnortherncalifornia |